Related Experiment Videos
[Neuroleptics with prolonged action]
Neurologia, Neurocirugia, Psiquiatria
|January 1, 1976
Summary
Long-acting neuroleptic drugs show significant progress in managing psychotic patients. These advanced medications offer new hope and improved outcomes for individuals undergoing psychiatric treatment.
Area of Science:
- Pharmacology
- Psychiatry
- Neuroscience
Context:
- Long-acting neuroleptic drug development has advanced significantly over the past two decades.
- Maintenance therapy for psychotic patients has seen promising progress.
- Current treatments include phenothiazine derivatives and esterifiable drugs.
Purpose:
- To review the progress and impact of long-acting neuroleptic drugs in psychiatric care.
- To highlight the evolution of pharmacological treatments for psychosis.
- To discuss the clinical utility of various long-acting neuroleptic drug classes.
Summary:
- The review covers phenothiazines (thioridazine), esterifiable phenothiazines (perphenazine, fluphenazine, pipothiazine), thioxanthenes (flupenthizol), butyrophenones (chlofluperol), and diphenylbutylpiperidines (fluspirilene, pimozide, penfluridol).
- Clinical studies indicate these long-acting agents represent a significant advancement in managing psychotic disorders.
- The development of these drugs signifies a new era in psychopharmacology.
Impact:
- Long-acting neuroleptics offer improved adherence and potentially better outcomes for patients with chronic psychotic conditions.
- These medications represent a revolutionary step in pharmacological psychiatry.
- Future perspectives in patient care are enhanced by the availability of these advanced treatments.